...
机译:ZnO纳米颗粒催化剂在合成生物活性熔融嘧啶作为靶向VEGFR-2的抗乳腺癌剂
Chemistry of Natural and Microbial Products Department Pharmaceutical and Drug Industries Research;
Chemistry of Natural and Microbial Products Department Pharmaceutical and Drug Industries Research;
Department of Chemistry Faculty of Science Cairo University Giza;
Biochemistry Department Genetic Engineering and Biotechnology Research Division National Research;
Biochemistry Department Genetic Engineering and Biotechnology Research Division National Research;
ZnO(NPs); fused pyrimidines; anti-breast cancer; VEGFR-2 inhibitory effect; heteroamines;
机译:ZnO纳米颗粒催化剂在合成生物活性熔融嘧啶作为靶向VEGFR-2的抗乳腺癌剂
机译:设计,合成和评价双重靶向ERα和VEGFR-2的6-芳基茚基异喹诺酮衍生物作为抗乳腺癌药物
机译:2,3-二芳基异喹啉酮衍生物作为针对ERα和VEGFR-2的抗乳腺癌药物的合成及生物学评价
机译:作为抗乳腺癌剂的取代四氢异喹啉的合成
机译:基于嘧啶的杂环作为潜在抗癌剂的设计与合成,具有组合化疗潜力或靶向一种碳代谢抑制和抗机会性药物
机译:活性天然产物的结构简化与多元合成。 3.熔融尿嘧啶含杂环作为新型拓扑异构酶靶向剂
机译:具有多组分合成的生物活性天然产物的结构简化。 3.融合的含尿嘧啶的杂环作为新型拓扑异构酶靶向剂。